IMC-Chicago, LLC

Position in BMY — Bristol Myers Squibb Co

CIK 1452861 CHICAGO, IL

Back to BMY Full portfolio

Position in BMY

as of Jun 30, 2026 · filed Aug 6, 2026 Compact

Position Value

$7,384,406

+$4,906,673 QoQ

Shares Held

128,157

+179.0% QoQ

Ownership

0.006%

of shares outstanding

% of Portfolio

0.07%

of 13F equity value

Holder Rank

#448

of 2,506 holders

Holding Since

Dec 2020

7 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Common Shares in BMY Over Time

Shares Held

Position Value (USD)

Derivatives in BMY

reported options exposure · as of Sep 30, 2021

CallValue

$9,408,030

CallShares

159,000

PutValue

$7,171,404

PutShares

121,200

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

IMC-Chicago, LLC holds $56,648,218 across 9 Drug Manufacturers - General names. BMY ranks #2 (13.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	25,449	$30,524,296
2	BMY	Bristol Myers Squibb Co This page	128,157	$7,384,406
3	BIIB	Biogen Inc.	20,649	$4,461,422
4	PFE	Pfizer Inc	173,689	$4,182,431
5	AMGN	Amgen Inc	8,927	$3,232,645
6	GILD	Gilead Sciences, Inc.	23,216	$2,933,109
7	NVS	Novartis AG	9,740	$1,526,452
8	AZN	Astrazeneca PLC	7,754	$1,470,313

All Filings in BMY

Export CSV

8 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$7,384,406	128,157	+179.0%	Shares	Sole	2026-08-06
2025-12-31	$2,477,733	45,935	+217.6%	Shares	Sole	2026-01-29
2023-03-31	$1,002,499	14,464	-31.8%	Shares	Sole	2023-04-24
2022-12-31	$1,526,563	21,217	+67.4%	Shares	Sole	2023-04-24
2021-09-30	$9,408,030	159,000	—	Call	Sole	2021-11-05
2021-09-30	$7,171,404	121,200	—	Put	Sole	2021-11-05
2021-06-30	$846,876	12,674	-65.7%	Shares	Sole	2021-08-06
2020-12-31	$2,293,249	36,970	—	Shares	Sole	2021-02-17
No filing history on record for this holder in this stock.